MARKET

GRAL

GRAL

Grail Inc
NASDAQ
67.19
-0.67
-0.99%
After Hours: 66.85 -0.34 -0.51% 19:15 05/22 EDT
OPEN
68.32
PREV CLOSE
67.86
HIGH
69.62
LOW
66.89
VOLUME
410.94K
TURNOVER
--
52 WEEK HIGH
118.84
52 WEEK LOW
29.95
MARKET CAP
2.88B
P/E (TTM)
-6.4773
1D
5D
1M
3M
1Y
5Y
1D
Grail posts Medicare study on ED-linked cancer diagnoses, higher costs
PUBT · 5d ago
Grail posts MCED study presentation on reducing emergency cancer diagnoses via ED
PUBT · 5d ago
This Beaten-Down Growth Stock Could Soar 30%, According to Wall Street
The Motley Fool · 5d ago
Assessing GRAIL (GRAL) Valuation As Galleri Demand Grows And FDA And NHS Updates Progress
Simply Wall St · 6d ago
Weekly Report: what happened at GRAL last week (0511-0515)?
Weekly Report · 6d ago
How GRAIL’s Narrowed Q1 2026 Loss Profile Will Impact GRAIL (GRAL) Investors
Simply Wall St · 05/14 12:32
GRAIL Inc (GRAL) Gets a Hold from Morgan Stanley
TipRanks · 05/12 13:06
Weekly Report: what happened at GRAL last week (0504-0508)?
Weekly Report · 05/11 10:00
More
About GRAL
Grail, Inc. is a healthcare company focused on saving lives and shifting the paradigm in early cancer detection. The Company is focused on alleviating the global burden of cancer by using sequencing, population-scale clinical studies, and machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. Its targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. Its multi-cancer early detection test, the Galleri test, is a commercially available screening test for early detection of multiple types of cancer. The Galleri test can be used to screen for cancer before a person becomes symptomatic, when cancer may be more easily treated and potentially curable. The Galleri test can indicate the origin of the cancer.

Webull offers Grail Inc stock information, including NASDAQ: GRAL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GRAL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GRAL stock methods without spending real money on the virtual paper trading platform.